[HTML][HTML] Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation

UM Zanger, M Schwab - Pharmacology & therapeutics, 2013 - Elsevier
Cytochromes P450 (CYP) are a major source of variability in drug pharmacokinetics and
response. Of 57 putatively functional human CYPs only about a dozen enzymes, belonging …

Cytochrome P450 in pharmacogenetics: an update

A Tornio, JT Backman - Advances in pharmacology, 2018 - Elsevier
Interindividual variability in drug disposition is a major cause of lack of efficacy and adverse
effects of drug therapies. The majority of hepatically cleared drugs are metabolized by …

[KIRJA][B] Hayes' principles and methods of toxicology

AW Hayes, T Kobets - 2023 - taylorfrancis.com
Hayes' Principles and Methods of Toxicology has long been established as a reliable and
informative reference for the concepts, methodologies, and assessments integral to …

Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study

AT Nordestgaard, M Thomsen… - International journal of …, 2015 - academic.oup.com
Background: Coffee is one of the most widely consumed beverages. We tested the
hypothesis that genetically high coffee intake is associated with low risk of obesity, metabolic …

Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products

GD Anderson, LN Chan - Clinical pharmacokinetics, 2016 - Springer
Tobacco smoke contains a large number of compounds in the form of metals, volatile gases
and insoluble particles, as well as nicotine, a highly addictive alkaloid. Marijuana is the most …

Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles

P Di Gion, F Kanefendt, A Lindauer, M Scheffler… - Clinical …, 2011 - Springer
Pyrimidine (imatinib, dasatinib, nilotinib and pazopanib), pyridine (sorafenib) and pyrrole
(sunitinib) tyrosine kinase inhibitors (TKIs) are multi-targeted TKIs with high activity towards …

[HTML][HTML] New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases

J Lu, X Shang, W Zhong, Y Xu, R Shi… - Acta Pharmaceutica Sinica …, 2020 - Elsevier
Abstract Cytochrome P450 1A (CYP1A), one of the major CYP subfamily in humans, not only
metabolizes xenobiotics including clinical drugs and pollutants in the environment, but also …

Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption

MC Cornelis, KL Monda, K Yu, N Paynter… - PLoS …, 2011 - journals.plos.org
We report the first genome-wide association study of habitual caffeine intake. We included
47,341 individuals of European descent based on five population-based studies within the …

[HTML][HTML] Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)

S Wanwimolruk, V Prachayasittikul - EXCLI journal, 2014 - ncbi.nlm.nih.gov
It is well recognized that herbal supplements or herbal medicines are now commonly used.
As many patients taking prescription medications are concomitantly using herbal …

Impacts of caffeine during pregnancy

J Qian, Q Chen, SM Ward, E Duan, Y Zhang - Trends in Endocrinology & …, 2020 - cell.com
Epidemiological studies have revealed that caffeine consumption during pregnancy is
associated with adverse gestational outcomes, yet the underlying mechanisms remain …